Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis（RA）”

887 trials

Showing 20 of 887 results

Large-scale testing (Phase 3)Study completedNCT02046616
What this trial is testing

Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 133
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Not applicableStudy completedNCT03993548
What this trial is testing

KickStart30: A 30-Day Intervention for Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Chronic PainStressPsychological+2 more
University of Texas at Austin 13
Large-scale testing (Phase 3)Study completedNCT01142726
What this trial is testing

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 511
Not applicableUnknownNCT03715595
What this trial is testing

The Treat-to-target Study of RA Based on Smart System of Disease Management(SSDM)

Who this might be right for
Rheumatoid Arthritis
Peking University People's Hospital 2,200
Not applicableStudy completedNCT03599986
What this trial is testing

Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis

Who this might be right for
Active Rheumatoid Arthritis
Eva Pharma 398
Not applicableStudy completedNCT02564770
What this trial is testing

A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 167
Early research (Phase 1)Study completedNCT02867306
What this trial is testing

Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Global Development, Inc. 10
Large-scale testing (Phase 3)Ended earlyNCT00042406
What this trial is testing

Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker

Who this might be right for
Rheumatoid Arthritis
Genmab 83
Testing effectiveness (Phase 2)Study completedNCT00256919
What this trial is testing

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 51
Not applicableStudy completedNCT00056602
What this trial is testing

Clinically Important Changes in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 192
Testing effectiveness (Phase 2)Ended earlyNCT00583557
What this trial is testing

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Who this might be right for
Rheumatoid Arthritis
Human Genome Sciences Inc. 155
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07748728
What this trial is testing

TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
Hangzhou Highlightll Pharmaceutical Co., Ltd 90
Testing effectiveness (Phase 2)Study completedNCT02379091
What this trial is testing

Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Takeda 108
Post-approval studies (Phase 4)Study completedNCT02831855
What this trial is testing

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Pfizer 694
Not applicableEnded earlyNCT02078375
What this trial is testing

The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Johns Hopkins University 23
Post-approval studies (Phase 4)UnknownNCT00434200
What this trial is testing

Rheumatoid Arthritis Patients in Training

Who this might be right for
Rheumatoid Arthritis
Leiden University Medical Center 300
Post-approval studies (Phase 4)Study completedNCT03886038
What this trial is testing

Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER)

Who this might be right for
Rheumatoid ArthritisHealthy Controls
Region Skane 142
Large-scale testing (Phase 3)Study completedNCT01709578
What this trial is testing

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)

Who this might be right for
Rheumatoid Arthritis
Sanofi 546
Not applicableStudy completedNCT00661284
What this trial is testing

Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

Who this might be right for
Rheumatoid Arthritis
Chugai Pharmaceutical 189
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation